Home/Filings/4/0001181431-05-033430
4//SEC Filing

CLOSURE MEDICAL CORP 4

Accession 0001181431-05-033430

CIK 0001016006operating

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 3:34 PM ET

Size

26.7 KB

Accession

0001181431-05-033430

Insider Transaction Report

Form 4
Period: 2005-06-03
WARD BENNY
VP of Finance and CFO
Transactions
  • Disposition to Issuer

    Employee stock option (right to buy)

    2005-06-03$10.38/sh50,000$518,7500 total
    Exercise: $16.63Exp: 2010-05-03Common Stock (50,000 underlying)
  • Disposition to Issuer

    Employee stock option (right to buy)

    2005-06-03$7.13/sh25,000$178,1250 total
    Exercise: $19.88Exp: 2010-09-11Common Stock (25,000 underlying)
  • Disposition to Issuer

    Employee stock option (right to buy)

    2005-06-03$22.00/sh15,365$338,0300 total
    Exercise: $5.00Exp: 2006-05-28Common Stock (15,365 underlying)
  • Disposition to Issuer

    Employee stock option (right to buy)

    2005-06-03$2.25/sh5,728$12,8880 total
    Exercise: $24.75Exp: 2008-01-01Common Stock (5,728 underlying)
  • Disposition to Issuer

    Common Stock

    2005-06-03$27.00/sh200$5,4000 total
  • Disposition to Issuer

    Common Stock

    2005-06-03$27.00/sh11,822$319,1940 total
  • Disposition to Issuer

    Employee stock option (right to buy)

    2005-06-03$12.44/sh10,885$135,4090 total
    Exercise: $14.56Exp: 2009-09-15Common Stock (10,885 underlying)
  • Disposition to Issuer

    Employee stock option (right to buy)

    2005-06-03$3.51/sh20,000$70,2000 total
    Exercise: $23.49Exp: 2012-01-02Common Stock (20,000 underlying)
Footnotes (5)
  • [F1]Disposed of pursuant to the merger agreement between Closure Medical Corporation, Johnson & Johnson and Holden Merger Sub, Inc., a wholly owned subsidiary of Johnson & Johnson, in exchange for a cash payment of $27 per share on the effective date of the merger.
  • [F2]Amount includes shares acquired under the Employee Stock Purchase Plan at various times and disposed of pursuant to the merger agreement between Closure Medical Corporation, Johnson & Johnson and Holden Merger Sub, Inc., a wholly owned subsidiary of Johnson & Johnson, in exchange for a cash payment of $27 per share on the effective date of the merger.
  • [F3]This option, which provided for vesting in five equal installments commencing on the first anniversary of the date of the grant, was canceled in the merger pursuant to the terms of the merger agreement between Closure Medical Corporation, Johnson & Johnson and Holden Merger Sub, Inc., a wholly owned subsidiary of Johnson & Johnson, in exchange for a cash payment equal to the difference between $27 and the exercise price of the option.
  • [F4]This option, which provided for vesting in three equal installments when each of three increasing stock market prices were achieved, or in any event, in five equal installments commencing on the first anniversary of the date of the grant, was canceled in the merger pursuant to the terms of the merger agreement between Closure Medical Corporation, Johnson & Johnson and Holden Merger Sub, Inc., a wholly owned subsidiary of Johnson & Johnson, in exchange for a cash payment equal to the difference between $27 and the exercise price of the option.
  • [F5]This option, which provided for vesting in four equal installments commencing on the first anniversary of the date of the grant, was canceled in the merger pursuant to the terms of the merger agreement between Closure Medical Corporation, Johnson & Johnson and Holden Merger Sub, Inc., a wholly owned subsidiary of Johnson & Johnson, in exchange for a cash payment equal to the difference between $27 and the exercise price of the option.

Issuer

CLOSURE MEDICAL CORP

CIK 0001016006

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001016006

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 3:34 PM ET
Size
26.7 KB